ACCESS CHINA Forum @JPM WEEK 2021
Date and time
Location
Online event
Refund policy
No Refunds
ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders to China.
About this event
ACCESS CHINA Forum @JPM WEEK 2021
We cordially invite you to join our “ACCESS CHINA Forum @ JPM WEEK 2021” to be held online on Jan 4th-30th, 2021. This conference is the largest CHINA corporate access event during JPM WEEK. We expect to host 100 Company Presentations, 30 Keynote Speeches, 1000+ Participants, and 500+ 1x1 meetings.
ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations.
Company roadshows are divided into ten different therapeutical sessions and three special sessions:
Oncology (3 sessions)
Ophthalmology / orthopedics
Material / Platform Technology
IVD / Medical Devices
Autoimmune disease
CNS / Cardiovascular
Cell Therapy / Rare Disease
Genitourinary / gynecology / pediatric
Dermatology / Respiratory / Infectious Disease
Digestive System / Endocrine / NASH
Swiss Innovation Day
Israel Healthcare Showcase
MNC Track
View most updated Agenda here:
To learn more about the event, please click the link below:
To download xls application form, please click the link below:
DOWNLOAD APPLICATION
To submit your application please click the link below:
SUBMIT APPLICATION
Application【three steps 】
To apply for a “Presenting Slot”, you simply need to submit the application form accessible via the link you can find below. Once approved by Forum Organizing Committee, you will be offered the chance to present at ACCESS CHINA Forum @JPM WEEK. Presenting slots will be given out on a first come, first served basis.
SPONSORSHIP
As a sponsor, you will be able to maximize brand exposure: you will have 20min keynote speech slot/ 1x1 system access/ LOGO Presentation.
1x1 system
As of Dec 24, there are 60+ global companies and 100+ Chinese innovative biotech/pharma joined the 1x1 system.
PREVIOUS PARTICIPATIONS- 2020 AC EVENTS
YAFO Life Science is the investment banking division of YAFO Capital with a focus on global biopharma licensing, financing, and M&A, representing leading healthcare clients from the U.S., Europe, Israel, and Japan. YAFO Life Science is dedicated to bringing global pharmaceutical and medical device products to China.
Contact
- China: Wendi Xiang +86-137-3368-5995 wxiang@yafocapital.com
- Europe: Gian Dell Antonio +44 7425-307-383 gandrea@yafocapital.com